Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-03, Stock:ABBV, The news for the past five days is as follows:
2020-05-27: NEWS1: Top 1st-Quarter Buys of Steven Cohen's Firm.NEWS2: Point72 Asset Management Buys Micron Technology, Baxter.NEWS3: Top Ranked Income Stocks to Buy for May 27th.NEWS4: How Trading Your Own Retirement Can Fleece Your Financial Future - May 27, 2020.NEWS5: AbbVie, Ironwood to discontinue experimental IBS drug.NEWS6: AbbVie Presents New Data at the European E-Congress of Rheumatology (EULAR) 2020 Showcasing Depth of its Rheumatology Portfolio.
2020-05-28: NEWS1: Why it may take the travel industry a few years to get back to normal.NEWS2: Ironwood to Halt MD-7246 Development After Study Failure.NEWS3: Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?.
2020-05-29: NEWS1: Gilead Continues to Build Cancer Franchise.NEWS2: FDA Approves the First Oral Medication for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women.
2020-06-01: NEWS1: 3 Strong Pharmaceutical and Biotech Stocks to Buy for Coronavirus Immunity.NEWS2: AbbVie Unveils Deal for Potential Tumor-Fighting Drug.NEWS3: AbbVie Gets FDA Nod for Oriahnn to Control Menstrual Bleeding.NEWS4: AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis.NEWS5: Lilly's Cyramza Gets FDA Approval for First-Line Lung Cancer.NEWS6: AbbVie Wrapped Its $63 Billion Allergan Buyout — Is AbbVie Stock A Buy?.NEWS7: Allergan Aesthetics Launches Dedicated Multi-Channel Campaign To Contact Patients Who May Not Be Aware Of The BIOCELL® Recall And To Improve Tracking Information For U.S. Breast Implant Patients.NEWS8: Drugmaker Abbvie Teams Up With Jacobio To Develop Cancer Inhibitor.NEWS9: AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors.
2020-06-02: NEWS1: AbbVie (ABBV) Gains But Lags Market: What You Should Know.NEWS2: MARKETS: Dow surges into the close, up 268 points — YF Premium is bullish on Abbvie (ABBV).NEWS3: 7 High-Dividend Stocks With Durable Distributions.NEWS4: Biosimilars of Humira Have Saved Europe a Bundle, Study Says.NEWS5: Pharma Large And Mid-Caps Race Against COVID-19.NEWS6: AbbVie Invests in a Cancer Drug - How to Trade the Stock.NEWS7: These 2 charts show why record-high stock valuations shouldn’t worry investors.NEWS8: AbbVie Seeks US and EU Nods for Rinvoq for Psoriatic Arthritis.NEWS9: AbbVie Stock Affirmed Outperform at RBC on Allergan Potential.NEWS10: AstraZeneca Ranked Most Inventive, Roche Most Innovative.NEWS11: AbbVie Stock Has Room to Run After Allergan Merger, Argus Says.NEWS12: The Zacks Analyst Blog Highlights: Tencent, Abbvie and Reckitt Benckiser.NEWS13: Buy Lilly, AbbVie and Merck Stocks, J.P. Morgan Says, but Pfizer Is Still Expensive.NEWS14: 3 Stocks With Dividends Yielding More Than 3%.NEWS15: AbbVie Seeks Rinvoq Approval For Psoriatic Arthritis In US, Europe.NEWS16: Revance, Mylan Move Forward With Botox Rival; Analyst Sees Long Path Ahead.

Answer: Decrease